Literature DB >> 29616606

Streptococcal group A, C and G pharyngitis in school children: a prospective cohort study in Southern India.

J John Melbin Jose1, Kootallur N Brahmadathan2, Vinod J Abraham3, Chiung-Yu Huang4, David Morens5, Nancy P Hoe6, Dean A Follmann7, Richard M Krause.   

Abstract

Diagnosing streptococcal pharyngitis in children on the basis of clinical appearance and throat culture is complicated by high colonisation rates and by the ability of other pathogens to cause clinically similar disease. To characterise the epidemiology of Lancefield Group A, C and G β-haemolytic streptococcus (GAS, GCS and GGS, respectively) in children, we conducted a 2-year prospective study of 307 school children between 7 and 11 years old. GGS and GAS were commonly identified organisms both for silent streptococcal colonisation and symptomatic sore throat, while GCS was uncommonly found. Streptococcal culture positivity at the time of clinical pharyngitis was estimated to reflect true streptococcal pharyngitis in only 26% of instances, with the frequency varying from 54% for children rarely colonised to 1% for children frequently colonised. Numerous GAS emm types were identified, including several types previously associated with severe pharyngitis (e.g. emm types 1, 3 and 28). No severe complications were seen in any child. These data suggest that the clinical diagnosis of streptococcal pharyngitis is likely to remain difficult and that treatment decisions will remain clouded by uncertainty. There remains a need for organism-specific rapid point-of-care streptococcal diagnostic tests and tests that can distinguish between streptococcal colonisation and disease.

Entities:  

Keywords:  Epidemiology; streptococcal infections; surveillance

Mesh:

Year:  2018        PMID: 29616606      PMCID: PMC5957769          DOI: 10.1017/S095026881800064X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

Review 1.  Accuracy and precision of the signs and symptoms of streptococcal pharyngitis in children: a systematic review.

Authors:  Nader Shaikh; Nithya Swaminathan; Emma G Hooper
Journal:  J Pediatr       Date:  2011-11-01       Impact factor: 4.406

2.  The Serological Classification of Streptococcus pyogenes.

Authors:  F Griffith
Journal:  J Hyg (Lond)       Date:  1934-12

3.  Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students.

Authors:  J C Turner; F G Hayden; M C Lobo; C E Ramirez; D Murren
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Molecular characterization of the 2011 Hong Kong scarlet fever outbreak.

Authors:  Herman Tse; Jessie Y J Bao; Mark R Davies; Peter Maamary; Hoi-Wah Tsoi; Amy H Y Tong; Tom C C Ho; Chi-Ho Lin; Christine M Gillen; Timothy C Barnett; Jonathan H K Chen; Mianne Lee; Wing-Cheong Yam; Chi-Kin Wong; Cheryl-Lynn Y Ong; Yee-Wai Chan; Cheng-Wei Wu; Tony Ng; Wilina W L Lim; Thomas H F Tsang; Cindy W S Tse; Gordon Dougan; Mark J Walker; Si Lok; Kwok-Yung Yuen
Journal:  J Infect Dis       Date:  2012-05-21       Impact factor: 5.226

5.  Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.

Authors:  T Bruun; B R Kittang; B J de Hoog; S Aardal; H K Flaatten; N Langeland; H Mylvaganam; H A Vindenes; S Skrede
Journal:  Clin Microbiol Infect       Date:  2013-06-25       Impact factor: 8.067

Review 6.  Rheumatic fever in the 21st century.

Authors:  G H Stollerman
Journal:  Clin Infect Dis       Date:  2001-08-13       Impact factor: 9.079

Review 7.  New trends of an old disease: the acute post infectious glomerulonephritis at the beginning of the new millenium.

Authors:  Piero Stratta; Claudio Musetti; Antonella Barreca; Gianna Mazzucco
Journal:  J Nephrol       Date:  2014-01-31       Impact factor: 3.902

8.  Clinical symptoms and signs in sore throat patients with large colony variant beta-haemolytic streptococci groups C or G versus group A.

Authors:  Morten Lindbaek; Ernst Arne Høiby; Gro Lermark; Inger Marie Steinsholt; Per Hjortdahl
Journal:  Br J Gen Pract       Date:  2005-08       Impact factor: 5.386

9.  Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children.

Authors:  Pallaval V Bramhachari; Santosh Y Kaul; David J McMillan; Melkote S Shaila; Mohan G Karmarkar; Kadaba S Sriprakash
Journal:  J Med Microbiol       Date:  2009-10-15       Impact factor: 2.472

10.  Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, southern India.

Authors:  Silvana Reissmann; Claudia Friedrichs; Reena Rajkumari; Andreas Itzek; Marcus Fulde; Arne C Rodloff; Kootallur N Brahmadathan; Gursharan S Chhatwal; D Patric Nitsche-Schmitz
Journal:  Emerg Infect Dis       Date:  2010-04       Impact factor: 6.883

View more
  4 in total

1.  Additive-Multiplicative Rates Model for Recurrent Event Data with Intermittently Observed Time-Dependent Covariates.

Authors:  Tianmeng Lyu; Xianghua Luo; Yifei Sun
Journal:  J Data Sci       Date:  2021-11-04

2.  Additive rates model for recurrent event data with intermittently observed time-dependent covariates.

Authors:  Tianmeng Lyu; Xianghua Luo; Chiung-Yu Huang; Yifei Sun
Journal:  Stat Methods Med Res       Date:  2021-08-26       Impact factor: 2.494

3.  The global burden of sore throat and group A Streptococcus pharyngitis: A systematic review and meta-analysis.

Authors:  Kate M Miller; Jonathan R Carapetis; Chris A Van Beneden; Daniel Cadarette; Jessica N Daw; Hannah C Moore; David E Bloom; Jeffrey W Cannon
Journal:  EClinicalMedicine       Date:  2022-05-20

4.  Streptococcus pyogenes strains associated with invasive and non-invasive infections present possible links with emm types and superantigens.

Authors:  Rao Muhammad Abid Khan; Sana Anwar; Zaid Ahmed Pirzada
Journal:  Iran J Basic Med Sci       Date:  2020-01       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.